Massivemarkets

OPK

Opko Health Inc.

Nasdaq · usd

$1.62+0.00 (+0.00%)
At close · 15-minute delayed
$1.64+0.02 (+1.22%)
As of 4:33:22 PM EST on Nov 17, 2026 · After hours

Opko Health Inc. (OPK) trades at $1.62 (+0.00%) as of 4:33:22 PM EST on Nov 17, 2026, +0.62% over the past month. Market cap is $1.2B, with 9.2 days to cover in short interest.

Stock performance

How Opko Health Inc. (OPK) stock has performed from one day to one year, with its 52-week range.

-0.02%
-$0.00 over 1D
$1.59$1.61$1.63$1.647:00 AM10:45 AM12:35 PM2:20 PM4:05 PM$1.62
1D
+0.00%
1W
-5.26%
1M
+0.62%
YTD
+28.57%
1Y
+26.56%
52-wk range
$0.98 – $1.86

Key statistics

Today's trading snapshot for OPK: day range, open, previous close, volume and market cap.

Day range
$1.59 – $1.65
Open
$1.60
Prev close
$1.62
Volume
3.03M
Market cap
$1.2B
Shares out
742.51M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Opko Health Inc.: P/E, P/S, P/B, ROE and more.

P/E
—
P/S
2.40
P/B
1.08
P/FCF
—
ROE
-13.3%
ROA
-7.9%
Debt/Equity
0.43
Div yield
0.00%

As of Nov 16, 2026

8-K filings

Material corporate events Opko Health Inc. has disclosed to the SEC on Form 8-K.

  • On November 4, 2026, OPKO Health, Inc. (the "Company") issued a press release announcing operating and financial highlights for the quarter ended September 30, 2026.

  • Divestiture agreementOct 15, 2026

    On October 14, 2026, OPKO Health, Inc., its wholly owned subsidiary, BioReference Health, LLC, and Laboratory Corporation of America Holdings entered into an Asset Purchase Agreement. Pursuant to the Purchase Agreement, Seller has agreed to sell and assign to Buyer certain assets of BioReference's clinical and anatomic pathology laboratory testing business, together with certain liabilities related to the Business.

  • Guarantee or letter of creditAug 14, 2026

    its wholly-owned subsidiaries OPKO Biologics Ltd. ("OBL") and EirGen Pharma Limited ("EirGen") as guarantors (OBL and EirGen collectively, the "Guarantors")... The Guarantors have guaranteed the obligations under the Notes and have granted a security interest in certain assets of the Guarantors.

  • Director appointmentMar 19, 2026

    On March 18, 2026, the Board of Directors of OPKO Health, Inc. (the "Company"), appointed Subbarao V. Uppaluri, Ph.D. as a new director with immediate effect to serve until the Company's 2026 Annual Meeting of Stockholders and until his successor shall be duly elected or appointed or his earlier death or resignation. Dr. Uppaluri is expected to be appointed to the Compensation Committee of the Board. The Board has determined that Dr. Uppaluri is independent under the applicable rules of the Securities and Exchange Commission and the Nasdaq Stock Market.

  • Divestiture agreementSep 15, 2025

    On March 10, 2025, OPKO, its wholly owned subsidiary, BioReference Health, LLC ('BioReference' and, together with OPKO, 'Seller'), and Laboratory Corporation of America Holdings, a Delaware corporation ('Buyer'), entered into an Asset Purchase Agreement (the 'Purchase Agreement'), pursuant to which Seller agreed to sell and assign to Buyer certain assets and liabilities of BioReference's laboratory testing businesses focused on oncology and oncology-related clinical testing services across the United States, in exchange for an aggregate purchase price of up to $225,000,000 in cash.

OPK short interest

How heavily OPK is shorted: shares short, days to cover and average daily volume.

Days to cover
9.2
Short interest
32.85M
Avg volume
3.56M

As of · reported to FINRA twice monthly.

OPK news

The latest news and headlines about Opko Health Inc. (OPK).

Frequently asked questions

What is the Opko Health Inc. (OPK) stock price today?

Opko Health Inc. (OPK) is trading at $1.62 (+0.00% on the day) as of 4:33:22 PM EST on Nov 17, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Opko Health Inc.?

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics.

What is the short interest in OPK?

As of Oct 30, 2026, OPK has 32.85M shares short and 9.2 days to cover.

What exchange is OPK listed on?

Opko Health Inc. (OPK) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

Build with AI

Build an analysis of OPK with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a OPK analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.